Shots:
- The US FDA has granted 510(k) clearance to ROSA Knee with OptimiZe, an enhanced version of the ROSA Knee system designed to support accurate, reproducible outcomes in robotic-assisted knee replacement surgery, with targeted rollout planned for late 2025 & broader US availability expected in Q1’26
- The system introduces new features, incl. customizable surgical plan, enhanced landmarking & tracking tools, automated kinematic alignment, & a simplified user interface to tailor user experience for every case
- Designed for the Persona Knee platform & integrated with ZBEdge Analytics, the system allows customizable surgeon profiles for functional alignment to automate implant positioning & knee balancing based on patient anatomy while supporting data-driven intra-operative decisions
Ref: Zimmer Biomet | Image: Zimmer Biomet |Press Release
Related News:- The US FDA Grants 510(k) Clearance to Zimmer Biomet’s Persona Revision SoluTion Femur
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
